ArticleJournal of inflammation research2026
Efficacy of Secukinumab in Chinese Patients with Moderate-to-Severe Hidradenitis Suppurativa: A 16-Week, Single-Center, Prospective, Real-World Study.
Chao Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.